Literature DB >> 2981753

Serum levels of estrogens and testosterone in cirrhotic men with and without hepatocellular carcinoma.

N Nagasue, Y Ogawa, H Yukaya, N Ohta, A Ito.   

Abstract

Serum levels of estrogens and testosterone were measured in 25 male patients with hepatocellular carcinoma and associated cirrhosis of the liver and in another 25 male patients with cirrhosis only. The two groups were statistically comparable in terms of age distribution, duration of liver disease, incidence of alcohol abuse, incidence of hepatitis B surface antigenemia, and grade of hepatic dysfunction. Estrone was significantly elevated in both groups of patients. Estradiol concentrations were above normal in 10 patients with hepatocellular carcinoma and in 11 with cirrhosis only. All patients had normal concentrations of estriol. There were no statistical differences between the two groups in either individual or total estrogen levels (estrone 0.05 less than p less than 0.1). Eight of the patients with hepatocellular carcinoma and 5 of the cirrhotics had lower testosterone levels than normal, but this difference was not significant. However, the estrone to testosterone ratios were significantly higher in the hepatocellular carcinoma group than in the cirrhosis group (p less than 0.05). The present study seems to indicate that hyperestrogenemia commonly seen in male patients with liver cirrhosis may play some role in hepatic carcinogenesis of cirrhotic livers. Further studies are needed to determine if the estrone to testosterone ratio is implicated in hepatocarcinogenesis in cirrhotic men.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2981753     DOI: 10.1016/0016-5085(85)90149-0

Source DB:  PubMed          Journal:  Gastroenterology        ISSN: 0016-5085            Impact factor:   22.682


  9 in total

1.  Two genes abrogate the inhibition of murine hepatocarcinogenesis by ovarian hormones.

Authors:  T M Poole; N R Drinkwater
Journal:  Proc Natl Acad Sci U S A       Date:  1996-06-11       Impact factor: 11.205

2.  Age-dependent sensitivity of Big Blue transgenic mice to the mutagenicity of N-ethyl-N-nitrosourea (ENU) in liver.

Authors:  Nan Mei; Robert H Heflich; Martha M Moore; Tao Chen
Journal:  Mutat Res       Date:  2005-05-02       Impact factor: 2.433

3.  Hepatocellular carcinoma in Asia: Prevention strategy and planning.

Authors:  Sara Ashtari; Mohamad Amin Pourhoseingholi; Afsaneh Sharifian; Mohamad Reza Zali
Journal:  World J Hepatol       Date:  2015-06-28

4.  Clinicopathologic comparisons between estrogen receptor-positive and -negative hepatocellular carcinomas.

Authors:  N Nagasue; H Kohno; Y C Chang; A Yamanoi; T Nakamura; H Yukaya; T Hayashi
Journal:  Ann Surg       Date:  1990-08       Impact factor: 12.969

5.  Hepatocellular carcinoma in Egypt: a single center study over a decade.

Authors:  Abdel-Rahman el-Zayadi; Hanaa M Badran; Eman M F Barakat; Mohy el-Deen Attia; Sherine Shawky; Mostafa K Mohamed; Osaima Selim; Ahmed Saeid
Journal:  World J Gastroenterol       Date:  2005-09-07       Impact factor: 5.742

6.  High Prevalence of Hormonal Changes and Hepatic Osteodystrophy in Frail Patients with Cirrhosis-An Observational Study.

Authors:  Surender Singh; Sunil Taneja; Puneeta Tandon; Arka De; Nipun Verma; Madhumita Premkumar; Ajay Duseja; Radha Krishan Dhiman; Virendra Singh
Journal:  J Clin Exp Hepatol       Date:  2021-11-26

7.  Cutaneous spider nevi in liver cirrhosis: capillary microscopical and hormonal investigations.

Authors:  M Pirovino; R Linder; C Boss; H P Köchli; F Mahler
Journal:  Klin Wochenschr       Date:  1988-04-01

8.  Clues to understanding the oxidation of estradiol in humans: effects of acute infectious hepatitis, autoimmune hepatitis, and chronic liver disease.

Authors:  Robert G Lahita; Robert A Schaefer; H Leon Bradlow; Mary Jeanne Kreek
Journal:  Ann N Y Acad Sci       Date:  2009-02       Impact factor: 5.691

9.  Disruption of the circadian clock component BMAL1 elicits an endocrine adaption impacting on insulin sensitivity and liver disease.

Authors:  Céline Jouffe; Benjamin D Weger; Eva Martin; Florian Atger; Meltem Weger; Cédric Gobet; Divya Ramnath; Aline Charpagne; Delphine Morin-Rivron; Elizabeth E Powell; Matthew J Sweet; Mojgan Masoodi; N Henriette Uhlenhaut; Frédéric Gachon
Journal:  Proc Natl Acad Sci U S A       Date:  2022-03-01       Impact factor: 12.779

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.